Therapeutic targeting of autophagy in myocardial infarction and heart failure

References

• World Health Organization. Global health estimates: deaths by cause, age, sex and country, 2000–2012. Geneva: WHO; 2014 [Internet]. Available from: http://www.who.int/healthinfo/global_burden_disease/estimates/en/index1.html
   Google Scholar
• Hausenloy DJ, Erik Botker H, Condorelli G, et al. Translating cardioprotection for patient benefit: position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res. 2013;98(1):7–27.
   PubMed Web of Science ®Google Scholar
• Hausenloy DJ, Yellon DM. Ischaemic conditioning and reperfusion injury. Nat Rev Cardiol. 2016;13(4):193–209.
   PubMed Web of Science ®Google Scholar
• Thygesen K, Alpert JS, White HD, et al. Universal definition of myocardial infarction. Circulation. 2007;116(22):2634–2653.
   PubMed Web of Science ®Google Scholar
• Cung TT, Morel O, Cayla G, et al. Cyclosporine before PCI in patients with acute myocardial infarction. N Engl J Med. 2015;373(11):1021–1031.
   PubMed Web of Science ®Google Scholar
• Okonko DO, Shah AM. Heart failure: mitochondrial dysfunction and oxidative stress in CHF. Nat Rev Cardiol. 2015;12(1):6–8.
   PubMed Web of Science ®Google Scholar
• Ambrosy AP, Fonarow GC, Butler J, et al. The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J Am Coll Cardiol. 2014;63(12):1123–1133.
   PubMed Web of Science ®Google Scholar
• Moran AE, Forouzanfar MH, Roth GA, et al. The global burden of ischemic heart disease in 1990 and 2010: the Global Burden of Disease 2010 study. Circulation. 2014;129(14):1493–1501.
   PubMed Web of Science ®Google Scholar
• Ibanez B, Heusch G, Ovize M, et al. Evolving therapies for myocardial ischemia/reperfusion injury. J Am Coll Cardiol. 2015;65(14):1454–1471.
   PubMed Web of Science ®Google Scholar
• Sivaraman V, Yellon DM. Pharmacologic therapy that simulates conditioning for cardiac ischemic/reperfusion injury. J Cardiovasc Pharmacol Ther. 2014;19(1):83–96.
   PubMed Web of Science ®Google Scholar
• Alpert JS, Thygesen K, Antman E, et al. Myocardial infarction redefined–a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000;36(3):959–969.
   PubMed Web of Science ®Google Scholar
• Hausenloy DJ, Yellon DM. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J Clin Invest. 2013;123(1):92–100.
   PubMed Web of Science ®Google Scholar
• Halestrap AP, Clarke SJ, Javadov SA. Mitochondrial permeability transition pore opening during myocardial reperfusion–a target for cardioprotection. Cardiovasc Res. 2004;61(3):372–385.
   PubMed Web of Science ®Google Scholar
• Shah AM, Mann DL. In search of new therapeutic targets and strategies for heart failure: recent advances in basic science. Lancet. 2011;378(9792):704–712.
   PubMed Web of Science ®Google Scholar
• Schiattarella GG, Magliulo F, Cattaneo F, et al. Novel molecular approaches in heart failure: seven trans-membrane receptors signaling in the heart and circulating blood leukocytes. Front Cardiovasc Med. 2015;2:13.
   PubMedGoogle Scholar
• Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;62(16):e147–e239.
   PubMed Web of Science ®Google Scholar
• Vicencio JM, Lavandero S, Szabadkai G. Ca2+, autophagy and protein degradation: thrown off balance in neurodegenerative disease. Cell Calcium. 2010;47(2):112–121.
   PubMed Web of Science ®Google Scholar
• Lavandero S, Troncoso R, Rothermel BA, et al. Cardiovascular autophagy: concepts, controversies, and perspectives. Autophagy. 2013;9(10):1455–1466.
   PubMed Web of Science ®Google Scholar
• Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell. 2008;132(1):27–42.
   PubMed Web of Science ®Google Scholar
• Vicencio JM, Galluzzi L, Tajeddine N, et al. Senescence, apoptosis or autophagy? When a damaged cell must decide its path–a mini-review. Gerontology. 2008;54(2):92–99.
   PubMed Web of Science ®Google Scholar
• Kim KH, Lee MS. Autophagy–a key player in cellular and body metabolism. Nat Rev Endocrinol. 2014;10(6):322–337.
   PubMed Web of Science ®Google Scholar
• Kim J, Kundu M, Viollet B, et al. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol. 2011;13(2):132–141.
   PubMed Web of Science ®Google Scholar
• Choi AM, Ryter SW, Levine B. Autophagy in human health and disease. N Engl J Med. 2013;368(7):651–662.
   PubMed Web of Science ®Google Scholar
• Klionsky DJ, Codogno P. The mechanism and physiological function of macroautophagy. J Innate Immun. 2013;5(5):427–433.
   PubMed Web of Science ®Google Scholar
• Fimia GM, Stoykova A, Romagnoli A, et al. Ambra1 regulates autophagy and development of the nervous system. Nature. 2007;447(7148):1121–1125.
   PubMed Web of Science ®Google Scholar
• Pankiv S, Clausen TH, Lamark T, et al. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem. 2007;282(33):24131–24145.
   PubMed Web of Science ®Google Scholar
• Lee E, Koo Y, Ng A, et al. Autophagy is essential for cardiac morphogenesis during vertebrate development. Autophagy. 2014;10(4):572–587.
   PubMed Web of Science ®Google Scholar
• Nakai A, Yamaguchi O, Takeda T, et al. The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat Med. 2007;13(5):619–624.
   PubMed Web of Science ®Google Scholar
• Endo Y, Furuta A, Nishino I. Danon disease: a phenotypic expression of LAMP-2 deficiency. Acta Neuropathol. 2015;129(3):391–398.
   PubMed Web of Science ®Google Scholar
• Wang G, Huang WQ, Cui SD, et al. Autophagy is involved in high glucose-induced heart tube malformation. Cell Cycle. 2015;14(5):772–783.
   PubMed Web of Science ®Google Scholar
• Taneike M, Yamaguchi O, Nakai A, et al. Inhibition of autophagy in the heart induces age-related cardiomyopathy. Autophagy. 2010;6(5):600–606.
   PubMed Web of Science ®Google Scholar
• Linton PJ, Gurney M, Sengstock D, et al. This old heart: cardiac aging and autophagy. J Mol Cell Cardiol. 2015;83:44–54.
   PubMed Web of Science ®Google Scholar
• Lavandero S, Chiong M, Rothermel BA, et al. Autophagy in cardiovascular biology. J Clin Invest. 2015;125(1):55–64.
   PubMed Web of Science ®Google Scholar
• Gatica D, Chiong M, Lavandero S, et al. Molecular mechanisms of autophagy in the cardiovascular system. Circ Res. 2015;116(3):456–467.
   PubMed Web of Science ®Google Scholar
• Ren J, Taegtmeyer H. Too much or not enough of a good thing–The Janus faces of autophagy in cardiac fuel and protein homeostasis. J Mol Cell Cardiol. 2015;84:223–226.
   PubMed Web of Science ®Google Scholar
• Troncoso R, Vicencio JM, Parra V, et al. Energy-preserving effects of IGF-1 antagonize starvation-induced cardiac autophagy. Cardiovasc Res. 2012;93(2):320–329.
   PubMed Web of Science ®Google Scholar
• Yang Y, Li Y, Chen X, et al. Exosomal transfer of miR-30a between cardiomyocytes regulates autophagy after hypoxia. J Mol Med. 2016;94(6):711–724.
   PubMed Web of Science ®Google Scholar
• Matsui Y, Takagi H, Qu X, et al. Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ Res. 2007;100(6):914–922.
   PubMed Web of Science ®Google Scholar
• Turer AT, Hill JA. Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy. Am J Cardiol. 2010;106(3):360–368.
   PubMed Web of Science ®Google Scholar
• Maejima Y, Isobe M, Sadoshima J. Regulation of autophagy by Beclin 1 in the heart. J Mol Cell Cardiol. 2015;95:19–25.
   PubMed Web of Science ®Google Scholar
• Huang Z, Han Z, Ye B, et al. Berberine alleviates cardiac ischemia/reperfusion injury by inhibiting excessive autophagy in cardiomyocytes. Eur J Pharmacol. 2015;762:1–10.
   PubMed Web of Science ®Google Scholar
• Hariharan N, Zhai P, Sadoshima J. Oxidative stress stimulates autophagic flux during ischemia/reperfusion. Antioxid Redox Signal. 2011;14(11):2179–2190.
   PubMed Web of Science ®Google Scholar
• Ma X, Liu H, Foyil SR, et al. Impaired autophagosome clearance contributes to cardiomyocyte death in ischemia/reperfusion injury. Circulation. 2012;125(25):3170–3181.
   PubMed Web of Science ®Google Scholar
• Zhu H, Tannous P, Johnstone JL, et al. Cardiac autophagy is a maladaptive response to hemodynamic stress. J Clin Invest. 2007;117(7):1782–1793.
   PubMed Web of Science ®Google Scholar
• Odashima M, Usui S, Takagi H, et al. Inhibition of endogenous Mst1 prevents apoptosis and cardiac dysfunction without affecting cardiac hypertrophy after myocardial infarction. Circ Res. 2007;100(9):1344–1352.
   PubMed Web of Science ®Google Scholar
• Maejima Y, Kyoi S, Zhai P, et al. Mst1 inhibits autophagy by promoting the interaction between Beclin1 and Bcl-2. Nat Med. 2013;19(11):1478–1488.
   PubMed Web of Science ®Google Scholar
• Xie M, Kong Y, Tan W, et al. Histone deacetylase inhibition blunts ischemia/reperfusion injury by inducing cardiomyocyte autophagy. Circulation. 2014;129(10):1139–1151.
   PubMed Web of Science ®Google Scholar
• Zhang J, Nadtochiy SM, Urciuoli WR, et al. The cardioprotective compound cloxyquin uncouples mitochondria and induces autophagy. Am J Physiol Heart Circ Physiol. 2016;310(1):H29–H38.
   PubMed Web of Science ®Google Scholar
• Huang L, Dai K, Chen M, et al. The AMPK agonist PT1 and mTOR inhibitor 3HOI-BA-01 protect cardiomyocytes after ischemia through induction of autophagy. J Cardiovasc Pharmacol Ther. 2016;21(1):70–81.
   PubMed Web of Science ®Google Scholar
• Yang K, Xu C, Li X, et al. Combination of D942 with curcumin protects cardiomyocytes from ischemic damage through promoting autophagy. J Cardiovasc Pharmacol Ther. 2013;18(6):570–581.
   PubMed Web of Science ®Google Scholar
• Huang Z, Ye B, Dai Z, et al. Curcumin inhibits autophagy and apoptosis in hypoxia/reoxygenation-induced myocytes. Mol Med Rep. 2015;11(6):4678–4684.
   PubMed Web of Science ®Google Scholar
• Hu Y, Sun Q, Li Z, et al. High basal level of autophagy in high-altitude residents attenuates myocardial ischemia-reperfusion injury. J Thorac Cardiovasc Surg. 2014;148(4):1674–1680.
   PubMed Web of Science ®Google Scholar
• Dammrich J, Pfeifer U. Cardiac hypertrophy in rats after supravalvular aortic constriction. II. Inhibition of cellular autophagy in hypertrophying cardiomyocytes. Virchows Arch B Cell Pathol Incl Mol Pathol. 1983;43(3):287–307.
   PubMedGoogle Scholar
• Shimomura H, Terasaki F, Hayashi T, et al. Autophagic degeneration as a possible mechanism of myocardial cell death in dilated cardiomyopathy. Jpn Circ J. 2001;65(11):965–968.
   PubMedGoogle Scholar
• Saito T, Asai K, Sato S, et al. Autophagic vacuoles in cardiomyocytes of dilated cardiomyopathy with initially decompensated heart failure predict improved prognosis. Autophagy. 2016;12(3):579–587.
   PubMed Web of Science ®Google Scholar
• Yu P, Zhang Y, Li C, et al. Class III PI3K-mediated prolonged activation of autophagy plays a critical role in the transition of cardiac hypertrophy to heart failure. J Cell Mol Med. 2015;19(7):1710–1719.
   PubMed Web of Science ®Google Scholar
• Zhang X, Min X, Li C, et al. Involvement of reductive stress in the cardiomyopathy in transgenic mice with cardiac-specific overexpression of heat shock protein 27. Hypertension. 2010;55(6):1412–1417.
   PubMed Web of Science ®Google Scholar
• Schiattarella GG, Hill JA. Therapeutic targeting of autophagy in cardiovascular disease. J Mol Cell Cardiol. 2015;95:86–93.
   PubMed Web of Science ®Google Scholar
• Khan S, Salloum F, Das A, et al. Rapamycin confers preconditioning-like protection against ischemia-reperfusion injury in isolated mouse heart and cardiomyocytes. J Mol Cell Cardiol. 2006;41(2):256–264.
   PubMed Web of Science ®Google Scholar
• Chen HH, Mekkaoui C, Cho H, et al. Fluorescence tomography of rapamycin-induced autophagy and cardioprotection in vivo. Circ Cardiovasc Imaging. 2013;6(3):441–447.
   PubMed Web of Science ®Google Scholar
• Hsu CP, Oka S, Shao D, et al. Nicotinamide phosphoribosyltransferase regulates cell survival through NAD+ synthesis in cardiac myocytes. Circ Res. 2009;105(5):481–491.
   PubMed Web of Science ®Google Scholar
• Hsu CP, Yamamoto T, Oka S, et al. The function of nicotinamide phosphoribosyltransferase in the heart. DNA Repair. 2014;23:64–68.
   PubMed Web of Science ®Google Scholar
• Hsu CP, Hariharan N, Alcendor RR, et al. Nicotinamide phosphoribosyltransferase regulates cell survival through autophagy in cardiomyocytes. Autophagy. 2009;5(8):1229–1231.
   PubMed Web of Science ®Google Scholar
• Yang Y, Duan W, Li Y, et al. Novel role of silent information regulator 1 in myocardial ischemia. Circulation. 2013;128(20):2232–2240.
   PubMed Web of Science ®Google Scholar
• Li Q, Xie J, Li R, et al. Overexpression of microRNA-99a attenuates heart remodelling and improves cardiac performance after myocardial infarction. J Cell Mol Med. 2014;18(5):919–928.
   PubMed Web of Science ®Google Scholar
• Higashi K, Yamada Y, Minatoguchi S, et al. MicroRNA-145 repairs infarcted myocardium by accelerating cardiomyocyte autophagy. Am J Physiol Heart Circ Physiol. 2015;309(11):H1813–H1826.
   PubMed Web of Science ®Google Scholar
• Wang K, Liu CY, Zhou LY, et al. APF lncRNA regulates autophagy and myocardial infarction by targeting miR-188-3p. Nat Commun. 2015;6:6779.
   PubMed Web of Science ®Google Scholar
• Bishu K, Ogut O, Kushwaha S, et al. Anti-remodeling effects of rapamycin in experimental heart failure: dose response and interaction with angiotensin receptor blockade. PloS one. 2013;8(12):e81325.
   Google Scholar
• Xie Z, Lau K, Eby B, et al. Improvement of cardiac functions by chronic metformin treatment is associated with enhanced cardiac autophagy in diabetic OVE26 mice. Diabetes. 2011;60(6):1770–1778.
   PubMed Web of Science ®Google Scholar
• Xu X, Lu Z, Fassett J, et al. Metformin protects against systolic overload-induced heart failure independent of AMP-activated protein kinase alpha2. Hypertension. 2014;63(4):723–728.
   PubMed Web of Science ®Google Scholar
• Yin M, van der Horst IC, van Melle JP, et al. Metformin improves cardiac function in a nondiabetic rat model of post-MI heart failure. Am J Physiol Heart Circ Physiol. 2011;301(2):H459–H468.
   PubMed Web of Science ®Google Scholar
• Kishore R, Krishnamurthy P, Garikipati VN, et al. Interleukin-10 inhibits chronic angiotensin II-induced pathological autophagy. J Mol Cell Cardiol. 2015;89(Pt B):203–213.
   PubMed Web of Science ®Google Scholar
• Samanta A, Dawn B. IL-10 for cardiac autophagy modulation: new direction in the pursuit of perfection. J Mol Cell Cardiol. 2016;91:204–206.
   PubMed Web of Science ®Google Scholar
• Shoji-Kawata S, Sumpter R, Leveno M, et al. Identification of a candidate therapeutic autophagy-inducing peptide. Nature. 2013;494(7436):201–206.
   PubMed Web of Science ®Google Scholar
• Wirawan E, Vanden Berghe T, Lippens S, et al. Autophagy: for better or for worse. Cell Res. 2012;22(1):43–61.
   PubMed Web of Science ®Google Scholar
• Chera S, Buzgariu W, Ghila L, et al. Autophagy in Hydra: a response to starvation and stress in early animal evolution. Biochim Biophys Acta. 2009;1793(9):1432–1443.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Estevez C, Salo E. Autophagy and apoptosis in planarians. Apoptosis. 2010;15(3):279–292.
   PubMed Web of Science ®Google Scholar
• Azevedo AS, Grotek B, Jacinto A, et al. The regenerative capacity of the zebrafish caudal fin is not affected by repeated amputations. PloS one. 2011;6(7):e22820.
   Google Scholar
• Varga M, Sass M, Papp D, et al. Autophagy is required for zebrafish caudal fin regeneration. Cell Death Differ. 2014;21(4):547–556.
   PubMed Web of Science ®Google Scholar
• Buja LM, Vela D. Cardiomyocyte death and renewal in the normal and diseased heart. Cardiovasc Pathol. 2008;17(6):349–374.
   PubMed Web of Science ®Google Scholar
• Leri A, Kajstura J, Anversa P. Role of cardiac stem cells in cardiac pathophysiology: a paradigm shift in human myocardial biology. Circ Res. 2011;109(8):941–961.
   PubMed Web of Science ®Google Scholar
• Omatsu-Kanbe M, Matsuura H. Ischemic survival and constitutively active autophagy in self-beating atypically-shaped cardiomyocytes (ACMs): characterization of a new subpopulation of heart cells. J Physiol Sci. 2013;63(1):17–29.
   PubMed Web of Science ®Google Scholar
• Breckwoldt K, Weinberger F, Eschenhagen T. Heart regeneration. Biochim Biophys Acta. 2015;1863(7 Pt B):1749–1759.
   PubMed Web of Science ®Google Scholar
• Uygur A, Lee RT. Mechanisms of cardiac regeneration. Dev Cell. 2016;36(4):362–374.
   PubMed Web of Science ®Google Scholar
• Finan A, Richard S. Stimulating endogenous cardiac repair. Front Dev Biol. 2015;3:57.
   PubMed Web of Science ®Google Scholar
• Schaun MI, Eibel B, Kristocheck M, et al. Cell therapy in ischemic heart disease: interventions that modulate cardiac regeneration. Stem Cells Int. 2016;2016:2171035.
   PubMed Web of Science ®Google Scholar
• Terzic A, Behfar A. Stem cell therapy for heart failure: ensuring regenerative proficiency. Trends Cardiovasc Med. 2016;26(5):395–404.
   PubMed Web of Science ®Google Scholar
• Madonna R, Van Laake LW, Davidson SM, et al. Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure. Eur Heart J. 2016;37(23):1789–1798.
   PubMed Web of Science ®Google Scholar
• Pan H, Cai N, Li M, et al. Autophagic control of cell ‘stemness’. EMBO Mol Med. 2013;5(3):327–331.
   PubMed Web of Science ®Google Scholar
• Zhang J, Liu J, Huang Y, et al. FRS2alpha-mediated FGF signals suppress premature differentiation of cardiac stem cells through regulating autophagy activity. Circ Res. 2012;110(4):e29–e39.
   PubMed Web of Science ®Google Scholar
• Zhang J, Liu J, Liu L, et al. The fibroblast growth factor signaling axis controls cardiac stem cell differentiation through regulating autophagy. Autophagy. 2012;8(4):690–691.
   PubMed Web of Science ®Google Scholar
• Chen T, Shen L, Yu J, et al. Rapamycin and other longevity-promoting compounds enhance the generation of mouse induced pluripotent stem cells. Aging Cell. 2011;10(5):908–911.
   PubMed Web of Science ®Google Scholar
• Karantalis V, Hare JM. Use of mesenchymal stem cells for therapy of cardiac disease. Circ Res. 2015;116(8):1413–1430.
   PubMed Web of Science ®Google Scholar
• Lee Y, Jung J, Cho KJ, et al. Increased SCF/c-kit by hypoxia promotes autophagy of human placental chorionic plate-derived mesenchymal stem cells via regulating the phosphorylation of mTOR. J Cell Biochem. 2013;114(1):79–88.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Yang M, Wang Y, et al. Autophagy regulates the apoptosis of bone marrow-derived mesenchymal stem cells under hypoxic condition via AMP-activated protein kinase/mammalian target of rapamycin pathway. Cell Biol Int. 2016;40(6):671–685.
   PubMed Web of Science ®Google Scholar
• Song C, Song C, Tong F. Autophagy induction is a survival response against oxidative stress in bone marrow-derived mesenchymal stromal cells. Cytotherapy. 2014;16(10):1361–1370.
   PubMed Web of Science ®Google Scholar
• Mazzoccoli G, Tevy MF, Borghesan M, et al. Caloric restriction and aging stem cells: the stick and the carrot? Exp Gerontol. 2014;50:137–148.
   PubMed Web of Science ®Google Scholar
• Garcia-Prat L, Martinez-Vicente M, Munoz-Canoves P. Autophagy: a decisive process for stemness. Oncotarget. 2016;7(11):12286–12288.
   PubMed Web of Science ®Google Scholar
• Vessoni AT, Muotri AR, Okamoto OK. Autophagy in stem cell maintenance and differentiation. Stem Cells Dev. 2012;21(4):513–520.
   PubMed Web of Science ®Google Scholar
• Ham O, Lee SY, Lee CY, et al. let-7b suppresses apoptosis and autophagy of human mesenchymal stem cells transplanted into ischemia/reperfusion injured heart 7by targeting caspase-3. Stem Cell Res Ther. 2015;6:147.
   PubMed Web of Science ®Google Scholar
• Gallo S, Sala V, Gatti S, et al. Cellular and molecular mechanisms of HGF/Met in the cardiovascular system. Clin Sci. 2015;129(12):1173–1193.
   PubMed Web of Science ®Google Scholar
• Gallo S, Gatti S, Sala V, et al. Agonist antibodies activating the Met receptor protect cardiomyoblasts from cobalt chloride-induced apoptosis and autophagy. Cell Death Dis. 2014;5:e1185.
   Google Scholar
• Neuss S, Becher E, Woltje M, et al. Functional expression of HGF and HGF receptor/c-met in adult human mesenchymal stem cells suggests a role in cell mobilization, tissue repair, and wound healing. Stem Cells. 2004;22(3):405–414.
   PubMed Web of Science ®Google Scholar
• Ellison GM, Torella D, Dellegrottaglie S, et al. Endogenous cardiac stem cell activation by insulin-like growth factor-1/hepatocyte growth factor intracoronary injection fosters survival and regeneration of the infarcted pig heart. J Am Coll Cardiol. 2011;58(9):977–986.
   PubMed Web of Science ®Google Scholar
• Koudstaal S, Bastings MM, Feyen DA, et al. Sustained delivery of insulin-like growth factor-1/hepatocyte growth factor stimulates endogenous cardiac repair in the chronic infarcted pig heart. J Cardiovasc Transl Res. 2014;7(2):232–241.
   PubMed Web of Science ®Google Scholar
• Chmielowiec J, Borowiak M, Morkel M, et al. c-Met is essential for wound healing in the skin. J Cell Biol. 2007;177(1):151–162.
   PubMed Web of Science ®Google Scholar
• Ishikawa T, Factor VM, Marquardt JU, et al. Hepatocyte growth factor/c-met signaling is required for stem-cell-mediated liver regeneration in mice. Hepatology. 2012;55(4):1215–1226.
   PubMed Web of Science ®Google Scholar
• Webster MT, Fan CM. c-MET regulates myoblast motility and myocyte fusion during adult skeletal muscle regeneration. PloS one. 2013;8(11):e81757.
   Google Scholar
• Troncoso R, Ibarra C, Vicencio JM, et al. New insights into IGF-1 signaling in the heart. Trends Endocrinol Metab. 2014;25(3):128–137.
   PubMed Web of Science ®Google Scholar
• Bagno LL, Carvalho D, Mesquita F, et al. Sustained IGF-1 secretion by adipose-derived stem cell improves infarcted heart function. Cell Transplant. 2015. [Epub ahead of print].
   PubMedGoogle Scholar
• Jackson R, Tilokee EL, Latham N, et al. Paracrine engineering of human cardiac stem cells with insulin-like growth factor 1 enhances myocardial repair. J Am Heart Assoc. 2015;4(9):e002104.
   PubMed Web of Science ®Google Scholar
• Cai WF, Wang L, Liu GS, et al. Manipulating the Hippo-Yap signal cascade in stem cells for heart regeneration. Ann Palliat Med. 2016;5(2):125–134.
   PubMed Web of Science ®Google Scholar
• Tian Y, Liu Y, Wang T, et al. A microRNA-Hippo pathway that promotes cardiomyocyte proliferation and cardiac regeneration in mice. Sci Transl Med. 2015;7(279):279ra238.
   Web of Science ®Google Scholar
• Cao DJ, Wang ZV, Battiprolu PK, et al. Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy. Proc Natl Acad Sci U S A. 2011;108(10):4123–4128.
   PubMed Web of Science ®Google Scholar
• Schiattarella GG, Hill JA. Inhibition of hypertrophy is a good therapeutic strategy in ventricular pressure overload. Circulation. 2015;131(16):1435–1447.
   PubMed Web of Science ®Google Scholar
• Wang C, Wang S, Zhao P, et al. MiR-221 promotes cardiac hypertrophy in vitro through the modulation of p27 expression. J Cell Biochem. 2012;113(6):2040–2046.
   PubMed Web of Science ®Google Scholar
• Su M, Wang J, Wang C, et al. MicroRNA-221 inhibits autophagy and promotes heart failure by modulating the p27/CDK2/mTOR axis. Cell Death Differ. 2015;22(6):986–999.
   PubMed Web of Science ®Google Scholar
• Ucar A, Gupta SK, Fiedler J, et al. The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy. Nat Commun. 2012;3:1078.
   PubMed Web of Science ®Google Scholar
• Li Z, Song Y, Liu L, et al. miR-199a impairs autophagy and induces cardiac hypertrophy through mTOR activation. Cell Death Differ. 2015. [Epub ahead of print].
   Google Scholar
• Pan W, Zhong Y, Cheng C, et al. MiR-30-regulated autophagy mediates angiotensin II-induced myocardial hypertrophy. PloS one. 2013;8(1):e53950.
   PubMed Web of Science ®Google Scholar
• Huang J, Sun W, Huang H, et al. miR-34a modulates angiotensin II-induced myocardial hypertrophy by direct inhibition of ATG9A expression and autophagic activity. PloS one. 2014;9(4):e94382.
   PubMed Web of Science ®Google Scholar
• Song L, Su M, Wang S, et al. MiR-451 is decreased in hypertrophic cardiomyopathy and regulates autophagy by targeting TSC1. J Cell Mol Med. 2014;18(11):2266–2274.
   PubMed Web of Science ®Google Scholar
• Viereck J, Kumarswamy R, Foinquinos A, et al. Long noncoding RNA Chast promotes cardiac remodeling. Sci Transl Med. 2016;8(326):326ra322.
   Web of Science ®Google Scholar
• Luther DJ, Thodeti CK, Meszaros JG. Injury models to study cardiac remodeling in the mouse: myocardial infarction and ischemia-reperfusion. Methods Mol Biol. 2013;1037:325–342.
   PubMedGoogle Scholar
• Aranguiz-Urroz P, Canales J, Copaja M, et al. Beta(2)-adrenergic receptor regulates cardiac fibroblast autophagy and collagen degradation. Biochim Biophys Acta. 2011;1812(1):23–31.
   PubMed Web of Science ®Google Scholar
• Georgescu SP, Aronovitz MJ, Iovanna JL, et al. Decreased metalloprotease 9 induction, cardiac fibrosis, and higher autophagy after pressure overload in mice lacking the transcriptional regulator p8. Am J Physiol Cell Physiol. 2011;301(5):C1046–C1056.
   Google Scholar
• Berry JM, Le V, Rotter D, et al. Reversibility of adverse, calcineurin-dependent cardiac remodeling. Circ Res. 2011;109(4):407–417.
   PubMed Web of Science ®Google Scholar
• He H, Liu X, Lv L, et al. Calcineurin suppresses AMPK-dependent cytoprotective autophagy in cardiomyocytes under oxidative stress. Cell Death Dis. 2014;5:e997.
   PubMed Web of Science ®Google Scholar
• Vakhrusheva O, Smolka C, Gajawada P, et al. Sirt7 increases stress resistance of cardiomyocytes and prevents apoptosis and inflammatory cardiomyopathy in mice. Circ Res. 2008;102(6):703–710.
   PubMed Web of Science ®Google Scholar
• Araki S, Izumiya Y, Rokutanda T, et al. Sirt7 contributes to myocardial tissue repair by maintaining transforming growth factor-beta signaling pathway. Circulation. 2015;132(12):1081–1093.
   PubMed Web of Science ®Google Scholar
• Ghavami S, Cunnington RH, Gupta S, et al. Autophagy is a regulator of TGF-beta1-induced fibrogenesis in primary human atrial myofibroblasts. Cell Death Dis. 2015;6:e1696.
   PubMed Web of Science ®Google Scholar
• Zou M, Wang F, Gao R, et al. Autophagy inhibition of hsa-miR-19a-3p/19b-3p by targeting TGF-beta R II during TGF-beta1-induced fibrogenesis in human cardiac fibroblasts. Sci Rep. 2016;6:24747.
   PubMed Web of Science ®Google Scholar
• Aguirre A, Montserrat N, Zacchigna S, et al. In vivo activation of a conserved microRNA program induces mammalian heart regeneration. Cell Stem Cell. 2014;15(5):589–604.
   PubMed Web of Science ®Google Scholar
• Seeger T, Xu QF, Muhly-Reinholz M, et al. Inhibition of let-7 augments the recruitment of epicardial cells and improves cardiac function after myocardial infarction. J Mol Cell Cardiol. 2016;94:145–152.
   PubMed Web of Science ®Google Scholar
• Shyh-Chang N, Daley GQ, Cantley LC. Stem cell metabolism in tissue development and aging. Development. 2013;140(12):2535–2547.
   PubMed Web of Science ®Google Scholar
• Jun-Hao ET, Gupta RR, Shyh-Chang N. Lin28 and let-7 in the metabolic physiology of aging. Trends Endocrinol Metab. 2016;27(3):132–141.
   PubMed Web of Science ®Google Scholar
• Dubinsky AN, Dastidar SG, Hsu CL, et al. Let-7 coordinately suppresses components of the amino acid sensing pathway to repress mTORC1 and induce autophagy. Cell Metab. 2014;20(4):626–638.
   PubMed Web of Science ®Google Scholar
• Jiang P, Mizushima N. Autophagy and human diseases. Cell Res. 2014;24(1):69–79.
   PubMed Web of Science ®Google Scholar